FDA
-
-
-
-
-
-
-
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
-
-
-
-
-
-
-
Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s
-
-
-
-
-
-
-
Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
-
-
-
-
-
-
Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technology
-
-
-
-
-
-
-
Anixa Biosciences (ANIX), Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application
-
-
-
-
-
-
-
Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy
-
-
-
-
-
-
-
Anixa Biosciences (ANIX) and Cleveland Clinic File IND Application for Breast Cancer Vaccine
-
325,857 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

